Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process

Authors

Institutions

Publication Details

Journal
The Lancet HIV
Published
2025-08-04
DOI
https://doi.org/10.1016/s2352-3018(25)00131-6
Citations
4
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
5.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process

Asa Radix, Sharon Walmsley, Miłosz Parczewski, Nicola Mackie et al.
4 citations
The Lancet HIV
HIV/AIDS Research and Interventions
5.58
article

Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process

Asa Radix, Sharon Walmsley, Miłosz Parczewski, Nicola Mackie, Marta Boffito, Simon Collins, Claudia P. Cortés, Jason Zucker, Chloe Orkin, François Venter, Itzchak Levy, Josep M. Llibre, Rick Elion, José Ramón Arribas, Magnus Gisslén, Sebastian Noé, Alain Volny‐Anne, Jean‐Michel Molina, Darrell H. S. Tan, William R. Short, Anna María Geretti, Alexa Elias, Daniel R. Kuritzkes, Kelly A. Gebo, Alexandra Calmy, Pedro Cahn, Carolyn Bolton‐Moore, Jennifer Hoy, Bruno Spire, Caroline Foster, Fiona V Cresswell, Carlos del Rı́o, Melanie Smuk, Vanessa Apea, Aniruddha Hazra, Melanie Thompson, Yvonne Gilleece, Jussi Sutinen, Estebán Martínez, Monica Gandhi, Judith S. Currier, Sara Paparini, Boghuma K Titanji, Kyle Ring, Mina John, Amy Paterson, Ferdinand W N M Wit, Mark O’Reilly, Laura Waters, Nagalingeswaran Kumarasamy, Nicholas I. Paton, Juergen Rockstroh, Cristina Mussini, Susan Cole‐Haley
article en
4 citations

Abstract

No abstract available for this paper.
The Lancet HIVVol. 12(9)
University of Rome Tor Vergata (IT), University of Modena and Reggio Emilia (IT), Brigham and Women's Hospital (US), St. Michael's Hospital (CA), University Health Network (CA), Université de Yaoundé I (CM), University of Helsinki (FI), Harvard University (US), Johns Hopkins University (US), Emory University (US), Imperial College Healthcare NHS Trust (GB), Inserm (FR), University of California, Los Angeles (US), National University of Singapore (SG), Queen Mary University of London (GB), Chicago Department of Public Health (US), University of California, San Francisco (US), University of Toronto (CA), George Washington University (US), Université Paris Cité (FR), Central and North West London NHS Foundation Trust (GB), University Hospital Bonn (DE), Columbia University Irving Medical Center (US), Royal Perth Hospital (AU), Sheba Medical Center (IL), Johns Hopkins Medicine (US), Chelsea and Westminster Hospital NHS Foundation Trust (GB), Helsinki University Hospital (FI), Hospital Universitario La Paz (ES), Voluntary Health Services Hospital (IN), University Hospital of Geneva (CH), Fundación Huésped (AR), Goethe Institut (DE), Hôpital Lariboisière (FR), Stichting HIV Monitoring (NL), Global Network of People Living with HIV/AIDS (NL), Center for HIV and Hepatogastroenterology (DE), Community Health Center (US), University Hospitals Sussex NHS Foundation Trust (GB), Economic & Social Sciences, Health Systems & Medical Informatics (FR), Institut de Recherche pour le Développement (FR), University College London (GB), Monash University (AU), Geneva College (US), University of Chile (CL), University of Pennsylvania (US), Pomeranian Medical University (PL), Thomas University (US)
Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, Sanofi, Gilead Sciences, Biogen, Emory University, Queen Mary University of London, ViiV Healthcare, Novocure, Moderna, Indian Council of Medical Research, National Institutes of Health, Center for AIDS Research, University of Washington, Cilag
Partnerships for the goals, Zero hunger
Openalex Percentile: Top 4%
HIV/AIDS Research and Interventions
5.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.